Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 174 | 3,894 | 4,470 | 13,800 | 16,339 |
| Gross Profit | 174 | 3,894 | 4,470 | 13,800 | 16,339 |
| Operating Expenses | 9,804 | 15,260 | 16,258 | 12,526 | 12,379 |
| Operating Income | -9,630 | -11,365 | -11,788 | 1,274 | 3,960 |
| Interest Expense | 391 | 401 | 421 | 503 | 547 |
| Other Income | 113 | 63 | 21 | 5 | 4 |
| Pre-tax Income | -9,908 | -11,704 | -12,188 | 777 | 3,417 |
| Income Tax | 9 | 33 | N/A | N/A | N/A |
| Net Income Continuous | -9,917 | -11,737 | -12,188 | 752 | 3,417 |
| Net Income | $-9,917 | $-11,737 | $-12,188 | $752 | $3,417 |
| EPS Basic Total Ops | -1.93 | -2.31 | -2.43 | 0.18 | 0.77 |
| EPS Basic Continuous Ops | -1.93 | -2.31 | -2.43 | 0.18 | 0.77 |
| EPS Diluted Total Ops | -1.93 | -2.31 | -2.43 | 0.30 | 0.56 |
| EPS Diluted Continuous Ops | -1.93 | -2.31 | -2.43 | 0.30 | 0.56 |
| EPS Diluted Before Non-Recurring Items | -1.93 | -2.31 | -2.43 | 0.11 | 0.56 |
| EBITDA(a) | $-9,567 | $-11,307 | $-11,727 | $1,920 | $4,045 |